Avant Brands, Inc. (AVTBF)
0.74
-0.01
(-0.92%)
USD |
OTCM |
Dec 19, 16:00
Avant Brands EPS Diluted (Quarterly): -0.1228 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.367M |
| Revenue (Quarterly) | 6.860M |
| Total Expenses (Quarterly) | 8.227M |
| Enterprise Value | 18.57M |
| Gross Profit Margin (Quarterly) | -15.27% |
| Profit Margin (Quarterly) | -19.92% |
| Earnings Yield | -192.7% |
| Normalized Earnings Yield | -115.11 |